276 related articles for article (PubMed ID: 26373564)
21. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.
Oen K; Tucker L; Huber AM; Miettunen P; Scuccimarri R; Campillo S; Cabral DA; Feldman BM; Tse S; Chédeville G; Spiegel L; Schneider R; Lang B; Ellsworth J; Ramsey S; Dancey P; Silverman E; Chetaille AL; Cameron B; Johnson N; Dorval J; Petty RE; Duffy KW; Boire G; Haddad E; Houghton K; Saint-Cyr C; Turvey SE; Benseler S; Cheang M; Yeung RS; Duffy CM
Arthritis Rheum; 2009 Aug; 61(8):1077-86. PubMed ID: 19644903
[TBL] [Abstract][Full Text] [Related]
22. Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: a community-based cohort study in Taiwan.
Shen CC; Yeh KW; Ou LS; Yao TC; Chen LC; Huang JL
J Microbiol Immunol Infect; 2013 Aug; 46(4):288-94. PubMed ID: 22727543
[TBL] [Abstract][Full Text] [Related]
23. Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study.
van der Meer A; Wulffraat NM; Prakken BJ; Gijsbers B; Rademaker CM; Sinnema G
Clin Exp Rheumatol; 2007; 25(3):480-5. PubMed ID: 17631750
[TBL] [Abstract][Full Text] [Related]
24. Burden of comorbid conditions in children and young people with juvenile idiopathic arthritis: a collaborative analysis of 3 JIA registries.
Kearsley-Fleet L; Klotsche J; van Straalen JW; Costello W; D'Angelo G; Giancane G; Horneff G; Klein A; Láday M; Lunt M; de Roock S; Ruperto N; Schoemaker C; Vijatov-Djuric G; Vojinovic J; Vougiouka O; Wulffraat NM; ; Hyrich KL; Minden K; Swart JF
Rheumatology (Oxford); 2022 May; 61(6):2524-2534. PubMed ID: 34613385
[TBL] [Abstract][Full Text] [Related]
25. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola EM; Pedersen R; Freundlich B; Chang DJ;
Ann Rheum Dis; 2008 Feb; 67(2):182-8. PubMed ID: 17728331
[TBL] [Abstract][Full Text] [Related]
26. Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.
Niehues T; Horneff G; Michels H; Höck MS; Schuchmann L; ;
Rheumatol Int; 2005 Apr; 25(3):169-78. PubMed ID: 15688190
[TBL] [Abstract][Full Text] [Related]
27. Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER.
Bethencourt Baute JJ; Sanchez-Piedra C; Ruiz-Montesinos D; Medrano San Ildefonso M; Rodriguez-Lozano C; Perez-Pampin E; Ortiz A; Manrique S; Roselló R; Hernandez V; Campos C; Sellas A; Sifuentes-Giraldo WA; García-González J; Sanchez-Alonso F; Díaz-González F; Gómez-Reino JJ; Bustabad Reyes S;
Arthritis Res Ther; 2018 Oct; 20(1):227. PubMed ID: 30305158
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.
Quartier P; Taupin P; Bourdeaut F; Lemelle I; Pillet P; Bost M; Sibilia J; Koné-Paut I; Gandon-Laloum S; LeBideau M; Bader-Meunier B; Mouy R; Debré M; Landais P; Prieur AM
Arthritis Rheum; 2003 Apr; 48(4):1093-101. PubMed ID: 12687553
[TBL] [Abstract][Full Text] [Related]
29. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
Weaver AL; Lautzenheiser RL; Schiff MH; Gibofsky A; Perruquet JL; Luetkemeyer J; Paulus HE; Xia HA; Leff JA;
Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444
[TBL] [Abstract][Full Text] [Related]
30. Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis.
Masi L; Ricci L; Zulian F; Del Monte F; Simonini G; Capannini S; De Martino M; Brandi ML; Falcini F
J Rheumatol; 2009 Oct; 36(10):2308-13. PubMed ID: 19684155
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept.
Borte S; Liebert UG; Borte M; Sack U
Rheumatology (Oxford); 2009 Feb; 48(2):144-8. PubMed ID: 19074187
[TBL] [Abstract][Full Text] [Related]
32. Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study.
Kunjir V; Venugopalan A; Chopra A
J Rheumatol; 2010 Aug; 37(8):1756-62. PubMed ID: 20516021
[TBL] [Abstract][Full Text] [Related]
33. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
Schmeling H; Biber D; Heins S; Horneff G
J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
[TBL] [Abstract][Full Text] [Related]
34. [Epidemiology of uveitis in juvenile idiopathic arthritis from a national paediatric rheumatologic and ophthalmologic database].
Heiligenhaus A; Niewerth M; Mingels A; Ganser G; Thon A; Pleyer U; Greiner K; Minden K
Klin Monbl Augenheilkd; 2005 Dec; 222(12):993-1001. PubMed ID: 16418970
[TBL] [Abstract][Full Text] [Related]
35. Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis.
Nielsen S; Ruperto N; Gerloni V; Simonini G; Cortis E; Lepore L; Alpigiani MG; Zulian F; Corona F; Alessio M; Barcellona R; Gallizzi R; Rossi F; Magni-Manzoni S; Lombardini G; Filocamo G; Raschetti R; Martini A; Ravelli A;
Clin Exp Rheumatol; 2008; 26(4):688-92. PubMed ID: 18799107
[TBL] [Abstract][Full Text] [Related]
36. Methotrexate/naproxen-associated severe hepatitis in a child with juvenile idiopathic arthritis.
Ting TV; Hashkes PJ
Clin Exp Rheumatol; 2007; 25(6):928-9. PubMed ID: 18173932
[TBL] [Abstract][Full Text] [Related]
37. Secukinumab-Induced Crohn's Disease in a Patient Treated for Juvenile Idiopathic Arthritis.
Edupuganti S; Khine S; Gupta R; Yadav D; Singh A
Cureus; 2023 Aug; 15(8):e43825. PubMed ID: 37736437
[TBL] [Abstract][Full Text] [Related]
38. Increased gut permeability in juvenile chronic arthritides. A multivariate analysis of the diagnostic parameters.
Picco P; Gattorno M; Marchese N; Vignola S; Sormani MP; Barabino A; Buoncompagni A
Clin Exp Rheumatol; 2000; 18(6):773-8. PubMed ID: 11138347
[TBL] [Abstract][Full Text] [Related]
39. Uveitis as a marker of active arthritis in 372 patients with juvenile idiopathic seronegative oligoarthritis or polyarthritis.
Kotaniemi K; Kotaniemi A; Savolainen A
Clin Exp Rheumatol; 2002; 20(1):109-12. PubMed ID: 11892693
[TBL] [Abstract][Full Text] [Related]
40. Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy.
Lahdenne P; Rapola J; Ylijoki H; Haapasaari J
J Rheumatol; 2002 Nov; 29(11):2442-5. PubMed ID: 12415606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
